Inhibition of p38 MAPK after repetitive mild TBI ameliorates immune signaling and behavioral deficits
Chenxing Li, Martin N. Griffin, Sydney E. Triplett, Anna E. Silverio, Elizabeth Pettit, Alivia M. Rohrer, Jacob P. Callaway, Pranavvarma V. Munagapati, Paul F. Saah, Paul I. Sanz, Felix G. Rivera Moctezuma, Erin M. Buckley, Levi Benjamin Wood
This study investigates the effects of p38 MAPK inhibition on immune signaling and behavioral deficits after repetitive mild TBI in mice, finding sex-dependent benefits in inflammation and functional outcomes.
bioRxiv · May 29, 2025 · PreprintMolecular Biology